{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "21267770",
  "DateCompleted": {
    "Year": "2011",
    "Month": "08",
    "Day": "01"
  },
  "DateRevised": {
    "Year": "2011",
    "Month": "04",
    "Day": "18"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1007/s10555-011-9275-2"
    ],
    "Journal": {
      "ISSN": "1573-7233",
      "JournalIssue": {
        "Volume": "30",
        "Issue": "2",
        "PubDate": {
          "Year": "2011",
          "Month": "Jun"
        }
      },
      "Title": "Cancer metastasis reviews",
      "ISOAbbreviation": "Cancer Metastasis Rev"
    },
    "ArticleTitle": "True local recurrences do not metastasize.",
    "Pagination": {
      "StartPage": "161",
      "EndPage": "176",
      "MedlinePgn": "161-76"
    },
    "Abstract": {
      "AbstractText": [
        "Generally, the limits of local tumor control are in part connected with the term \"field cancerization\" and are known from oral, lung, prostate, or mammary cancer. With the example of breast cancer (BC), the problem of ipsilateral breast tumor recurrences (IBTR) after breast-conserving surgery will be reviewed. Three types of local recurrences are distinguished: true recurrences, new primaries, or residual tumors. Good data for BC allow the description of the time-dependent risk of these three types, relative to the diagnosis of the primary tumor, because the time of initiation and the growth duration of the IBTR can be estimated. Two hypotheses explain the data: first, local recurrences may be initiated years before the diagnosis of a primary tumor (PT) and can then appear as multifocal PT at diagnosis, and second, true local recurrences probably do not metastasize. The generalizability of these hypotheses for other tumors will be discussed."
      ],
      "CopyrightInformation": "\u00a9 Springer Science+Business Media, LLC 2011"
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Munich Cancer Registry (MCR), Munich Cancer Center (MCC), Institute of medical Informatics, Biometry and Epidemiology (IBE), Ludwig-Maximilians-University (LMU) Munich, Munich, Germany. hoe@ibe.med.uni-muenchen.de"
          }
        ],
        "LastName": "H\u00f6lzel",
        "ForeName": "Dieter",
        "Initials": "D"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Emeny",
        "ForeName": "Rebecca T",
        "Initials": "RT"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Engel",
        "ForeName": "Jutta",
        "Initials": "J"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Review"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "Netherlands",
    "MedlineTA": "Cancer Metastasis Rev",
    "NlmUniqueID": "8605731",
    "ISSNLinking": "0167-7659"
  },
  "MeshHeadingList": [
    {
      "QualifierName": [
        "pathology",
        "surgery"
      ],
      "DescriptorName": "Breast Neoplasms"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Disease Progression"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Disease-Free Survival"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Female"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "methods"
      ],
      "DescriptorName": "Mastectomy"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Neoplasm Metastasis"
    },
    {
      "QualifierName": [
        "classification",
        "pathology"
      ],
      "DescriptorName": "Neoplasm Recurrence, Local"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Prognosis"
    }
  ]
}